Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Greenwich LifeSciences (GLSI)
NASDAQ:GLSI
Holding GLSI?
Track your performance easily
GLSI Stock Chart & Stats
Day’s Range― - ―
52-Week Range$8.00 - $21.44
Previous Close$13.65
Volume34.11K
Average Volume (3M)37.32K
Market Cap
$165.23M
Enterprise ValueN/A
Total Cash (Recent Filing)$85.10K
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.49
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.81
Shares Outstanding13,144,653
10 Day Avg. Volume47,564
30 Day Avg. Volume37,324
Standard Deviation0.85
R-Squared0.03
Alpha0.08
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-16.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Greenwich LifeSciences News
Ownership Overview
55.06% Insiders
3.17% Mutual Funds
0.14% Other Institutional Investors
38.00% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
GLSI FAQ
What was Greenwich LifeSciences’s price range in the past 12 months?
Greenwich LifeSciences lowest stock price was $8.00 and its highest was $21.44 in the past 12 months.
What is Greenwich LifeSciences’s market cap?
Greenwich LifeSciences’s market cap is $165.23M.
When is Greenwich LifeSciences’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Greenwich LifeSciences’s earnings last quarter?
Currently, no data Available
Is Greenwich LifeSciences overvalued?
According to Wall Street analysts Greenwich LifeSciences’s price is currently Overvalued.
Does Greenwich LifeSciences pay dividends?
Greenwich LifeSciences does not currently pay dividends.
What is Greenwich LifeSciences’s EPS estimate?
Greenwich LifeSciences’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Greenwich LifeSciences have?
Greenwich LifeSciences has 13,144,653 shares outstanding.
What happened to Greenwich LifeSciences’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Greenwich LifeSciences?
Currently, no hedge funds are holding shares in GLSI
---
Greenwich LifeSciences Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
43.63%
12-Months-Change
Fundamentals
Return on Equity
-151.72%
Trailing 12-Months
Asset Growth
-36.34%
Trailing 12-Months
Company Description
Greenwich LifeSciences
Greenwich LifeSciences Inc is a clinical stage bio-pharmaceutical company focused on the development of an immunotherapy to prevent breast cancer recurrences in patients.
---
GLSI Stock 12 Month Forecast
Average Price Target
―Technical Analysis
ADC Therapeutics
―
Cardiff Oncology
―
Cyclacel Pharmaceuticals
―
Eloxx Pharmaceuticals
―
Crispr Therapeutics AG
―
Best Analysts Covering GLSI
1 Year
1 Year Success Rate
2/7 ratings generated profit
1 Year Average Return
-6.51%
reiterated a buy rating 5 months ago
Copying Yi Chen's trades and holding each position for 1 Year would result in 28.57% of your transactions generating a profit, with an average return of -6.51% per trade.
---